(Q41465688)

1 October 2017

1 reference

title

New approaches in the treatment of metastatic transitional-cell cancer of the bladder (English)

1 reference

1 October 2017

Corral DA

1

1 reference

1 October 2017

Logothetis CJ

series ordinal

2

1 reference

1 October 2017

1 January 1997

1 reference

1 October 2017

World Journal of Urology

1 reference

1 October 2017

15

1 reference

1 October 2017

139-143

1 reference

1 October 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02201986

1 October 2017

0 references

cites work

Oral piritrexim, an effective treatment for metastatic urothelial cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02201986

Adenoviral-mediated gene transfer to bladder in vivo.

21 January 2018

1 reference

12 December 2020

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.

1 reference

12 December 2020

Preliminary experience with paclitaxel in advanced bladder cancer

1 reference

12 December 2020

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

12 December 2020

Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy

1 reference

12 December 2020

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

1 reference

12 December 2020

Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.

1 reference

12 December 2020

Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate

1 reference

12 December 2020

Combination Cisplatin and Dichloromethotrexate in Patients with Advanced Bladder Cancer. Phase 2. A Southwest Oncology Group Study

1 reference

12 December 2020

Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Carboplatin, methotrexate, vinblastine and epirubicin (Carbo-MVE) for transitional cell bladder carcinoma

1 reference

12 December 2020

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

12 December 2020

From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists

1 reference

12 December 2020

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

1 reference

12 December 2020

Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern

1 reference

12 December 2020

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

12 December 2020

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

12 December 2020

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

12 December 2020

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

1 reference

12 December 2020

Phase II trial of pirarubicin in the treatment of advanced bladder cancer

1 reference

12 December 2020

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

1 reference

12 December 2020

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

1 reference

12 December 2020

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

12 December 2020

[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]

1 reference

12 December 2020

Gallium nitrate in advanced bladdercarcinoma: Southwest oncology group study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02201986

1 reference

Dimensions Publication ID

1 October 2017

1034684394

0 references

Fatcat ID

release_v5rr5rcocve77pglpjf5r2fl2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v5rr5rcocve77pglpjf5r2fl2q

24 November 2022

mapped directly with Wikidata item

1 reference